124 related articles for article (PubMed ID: 12098579)
1. Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate receptor in the rat brain.
Castelli MP; Mocci I; Pistis M; Peis M; Berta D; Gelain A; Gessa GL; Cignarella G
Eur J Pharmacol; 2002 Jun; 446(1-3):1-5. PubMed ID: 12098579
[TBL] [Abstract][Full Text] [Related]
2. A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor.
Castelli MP; Pibiri F; Carboni G; Piras AP
CNS Drug Rev; 2004; 10(3):243-60. PubMed ID: 15492774
[TBL] [Abstract][Full Text] [Related]
3. Characterization and pharmacology of the GHB receptor.
Ticku MK; Mehta AK
Ann N Y Acad Sci; 2008 Oct; 1139():374-85. PubMed ID: 18991884
[TBL] [Abstract][Full Text] [Related]
4. Quantitative autoradiographic analysis of the new radioligand [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid ([(3)H]NCS-382) at gamma-hydroxybutyric acid (GHB) binding sites in rat brain.
Gould GG; Mehta AK; Frazer A; Ticku MK
Brain Res; 2003 Jul; 979(1-2):51-6. PubMed ID: 12850570
[TBL] [Abstract][Full Text] [Related]
5. Novel cyclic gamma-hydroxybutyrate (GHB) analogs with high affinity and stereoselectivity of binding to GHB sites in rat brain.
Wellendorph P; Høg S; Greenwood JR; de Lichtenberg A; Nielsen B; Frølund B; Brehm L; Clausen RP; Bräuner-Osborne H
J Pharmacol Exp Ther; 2005 Oct; 315(1):346-51. PubMed ID: 16014570
[TBL] [Abstract][Full Text] [Related]
6. Binding characteristics of the gamma-hydroxybutyric acid receptor antagonist [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid in the rat brain.
Mehta AK; Muschaweck NM; Maeda DY; Coop A; Ticku MK
J Pharmacol Exp Ther; 2001 Dec; 299(3):1148-53. PubMed ID: 11714906
[TBL] [Abstract][Full Text] [Related]
7. Novel radioiodinated {gamma}-hydroxybutyric acid analogues for radiolabeling and Photolinking of high-affinity {gamma}-hydroxybutyric acid binding sites.
Wellendorph P; Høg S; Sabbatini P; Pedersen MH; Martiny L; Knudsen GM; Frølund B; Clausen RP; Bräuner-Osborne H
J Pharmacol Exp Ther; 2010 Nov; 335(2):458-64. PubMed ID: 20696866
[TBL] [Abstract][Full Text] [Related]
8. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.
Kaupmann K; Cryan JF; Wellendorph P; Mombereau C; Sansig G; Klebs K; Schmutz M; Froestl W; van der Putten H; Mosbacher J; Bräuner-Osborne H; Waldmeier P; Bettler B
Eur J Neurosci; 2003 Nov; 18(10):2722-30. PubMed ID: 14656321
[TBL] [Abstract][Full Text] [Related]
9. Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonists.
Carter LP; Wu H; Chen W; Matthews MM; Mehta AK; Hernandez RJ; Thomson JA; Ticku MK; Coop A; Koek W; France CP
J Pharmacol Exp Ther; 2005 Jun; 313(3):1314-23. PubMed ID: 15769868
[TBL] [Abstract][Full Text] [Related]
10. Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid.
Castelli MP; Ferraro L; Mocci I; Carta F; Carai MA; Antonelli T; Tanganelli S; Cignarella G; Gessa GL
J Neurochem; 2003 Nov; 87(3):722-32. PubMed ID: 14535954
[TBL] [Abstract][Full Text] [Related]
11. Relation of the [3H] gamma-hydroxybutyric acid (GHB) binding site to the gamma-aminobutyric acidB (GABAB) receptor in rat brain.
Snead OC
Biochem Pharmacol; 1996 Oct; 52(8):1235-43. PubMed ID: 8937431
[TBL] [Abstract][Full Text] [Related]
12. Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid.
Carai MA; Colombo G; Reali R; Serra S; Mocci I; Castelli MP; Cignarella G; Gessa GL
Eur J Pharmacol; 2002 Apr; 441(3):157-63. PubMed ID: 12063087
[TBL] [Abstract][Full Text] [Related]
13. Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence.
Wu Y; Ali S; Ahmadian G; Liu CC; Wang YT; Gibson KM; Calver AR; Francis J; Pangalos MN; Carter Snead O
Neuropharmacology; 2004 Dec; 47(8):1146-56. PubMed ID: 15567424
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor.
Snead OC
J Neurochem; 2000 Nov; 75(5):1986-96. PubMed ID: 11032888
[TBL] [Abstract][Full Text] [Related]
15. gamma-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors.
Nava F; Carta G; Bortolato M; Gessa GL
Eur J Pharmacol; 2001 Nov; 430(2-3):261-3. PubMed ID: 11711039
[TBL] [Abstract][Full Text] [Related]
16. A tertiary alcohol analog of gamma-hydroxybutyric acid as a specific gamma-hydroxybutyric acid receptor ligand.
Wu H; Zink N; Carter LP; Mehta AK; Hernandez RJ; Ticku MK; Lamb R; France CP; Coop A
J Pharmacol Exp Ther; 2003 May; 305(2):675-9. PubMed ID: 12606613
[TBL] [Abstract][Full Text] [Related]
17. Ethanol does not alter the binding of the gamma-hydroxybutyric acid (GHB) receptor ligand [3H]NCS-382 in the rat brain.
Mehta AK; Muschaweck NM; Ticku MK
Drug Alcohol Depend; 2004 Sep; 75(3):323-5. PubMed ID: 15283953
[TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) in rats discriminating GHB from baclofen and diazepam.
Koek W; Carter LP; Lamb RJ; Chen W; Wu H; Coop A; France CP
J Pharmacol Exp Ther; 2005 Jul; 314(1):170-9. PubMed ID: 15774716
[TBL] [Abstract][Full Text] [Related]
19. Validation of high-affinity binding sites for succinic acid through distinguishable binding of gamma-hydroxybutyric acid receptor-specific NCS 382 antipodes.
Molnár T; Visy J; Simon A; Moldvai I; Temesvári-Major E; Dörnyei G; Fekete EK; Kardos J
Bioorg Med Chem Lett; 2008 Dec; 18(23):6290-2. PubMed ID: 18945616
[TBL] [Abstract][Full Text] [Related]
20. Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid.
Carai MA; Colombo G; Brunetti G; Melis S; Serra S; Vacca G; Mastinu S; Pistuddi AM; Solinas C; Cignarella G; Minardi G; Gessa GL
Eur J Pharmacol; 2001 Oct; 428(3):315-21. PubMed ID: 11689189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
